New savings for patients
Help your commercially insured patients reduce their medication cost
On average, patients paid $45 for 90 days (or $15 per month) for OTC artificial tears.1†
If your patient's pharmacy does not accept or process co-pay cards, he/she can get reimbursed for their costs. To access the form, please visit:
https://www.xiidrainsider.com/Content/pdf/Form.pdf.
*
Limitations apply. Valid for patients with private (commercial) insurance only. The Xiidra Co-pay card Program includes the Co-pay Card and rebate. Eligible, commercially-insured patients using the Co-pay Card pay $0 for their first prescription of Xiidra. $0 first fill available for prescriptions up to 90 days. After the first fill, eligible, commercially-insured patients may pay as little as $0 for prescriptions of Xiidra, subject to a maximum monthly savings of $250 for each 30-day prescription and $750 for each 90-day prescription. Patient is responsible for any costs once monthly savings limit is reached. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, or (iii) where the patient's insurance plan reimburses for the entire cost of the drug. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party, rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.
†Based on average dollars per month spent on over-the-counter dry eye products by patients active in both the IQVIA LRx and OTC databases (n=2,258,782). Eligible patients must have at least one record of prescription activity (from any market) in the LRx database prior to the look-back period and at least one record of OTC activity. Calculation was completed by IQVIA based on a study period from November 2018 to October 2019.
For patients experiencing financial hardship, and
have limited or no prescription coverage, contact 1-800-277-2254 or visit http://www.PAP.Novartis.com.
Patients who are eligible may receive their
medication for free.
Prior Authorization (PA) assistance is available along the PA journey
PA support can help patients gain access to appropriate therapy.
Remember
Your office can also initiate a PA—being proactive in the PA process may help improve your patient's access to appropriate therapy.
Remember
Your office can also initiate a PA—being proactive in the PA process may help improve your patient's access to appropriate therapy.
CoverMyMeds can help!
Reach out to schedule live demonstrations,
walk-throughs, and technical support.
Contact their support team Monday through Friday,
8 AM to 11 PM ET, and Saturday, 8 AM to 6 PM ET
Live Chat: CoverMyMeds.com
Phone: 1-866-452-5017